U.S. seeks patent protection for drugs, expert say
Published: 2012-03-19 06:56:00
Updated: 2012-03-19 06:56:00
The controversial patent linkage system is aimed at delaying the market organization of a drug to protect the interests of U.S. drug makers in the Korean domestic market under the Korea-U.S. free trade agreement (KORUS FTA), an expert said.
In a local seminar organized by the Korean Intellectu...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
